Wealth Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$789K Buy
13,692
+10,234
+296% +$588K 0.2% 68
2026
Q1
$210K Buy
+3,458
New +$202K 0.2% 83
2025
Q2
Sell
-3,558
Closed -$217K 104
2025
Q1
$217K Sell
3,558
-2,457
-41% -$143K 0.14% 147
2024
Q4
$340K Buy
+6,015
New +$336K 0.22% 102
2024
Q3
Sell
-5,560
Closed -$231K 155
2024
Q2
$231K Sell
5,560
-633
-10% -$28.3K 0.17% 135
2024
Q1
$336K Buy
+6,193
New +$315K 0.25% 101

Other funds holding BMY

Wealth Group's BMY Position: Q2 2026 in Review

Wealth Group increased its Bristol-Myers Squibb (BMY) stake by 296% in Q2 2026, buying an estimated $588K and bringing the position to 13,692 shares worth $789K. The position accounts for 0.2% of the portfolio, ranked #68.

Wealth Group first reported a position in BMY in Q1 2024 and has held it in 6 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Wealth Group held 13,692 shares of Bristol-Myers Squibb worth $789K as of Q2 2026.
  • Wealth Group bought 10,234 Bristol-Myers Squibb shares in Q2 2026, an estimated $588K.
  • Bristol-Myers Squibb made up 0.2% of Wealth Group's portfolio in Q2 2026, its #68 holding.
  • Wealth Group first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 6 quarters since.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.